Thu, Sep 18, 2014, 8:07 AM EDT - U.S. Markets open in 1 hr 23 mins


% | $
Quotes you view appear here for quick access.

OraSure Technologies, Inc. Message Board

thinkclearly007 2 posts  |  Last Activity: Aug 1, 2014 1:31 PM Member since: Apr 30, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Insys comments on the recent drop

    by thinkclearly007 Aug 1, 2014 12:41 PM
    thinkclearly007 thinkclearly007 Aug 1, 2014 1:31 PM Flag

    point was that the rumor was spread by spineless shorts about possibility of exclusion while the company is saying that they are doing fine

  • thinkclearly007 by thinkclearly007 Aug 1, 2014 12:41 PM Flag

    Insys Therapeutics Reaffirms Second Quarter 2014 Revenue Guidance

    PHOENIX, AZ--(Marketwired - Jun 30, 2014) - Insys Therapeutics, Inc. today reaffirmed its revenue guidance for the second quarter ended June 30, 2014. Revenue from sales of Subsys® (Fentanyl Sublingual Spray) is expected to exceed $52.0 million for the quarter, as compared with $18.5 million during the second quarter of 2013.

    The company plans to release its unaudited financial results for the second quarter ended June 30, 2014 before the U.S. financial markets open on Tuesday, August 12, 2014.

    I bought between $22.70 and $23.20

    Sentiment: Strong Buy

7.41+0.03(+0.41%)Sep 17 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.